Neutrophil-To-Lymphocyte Ratio as an Early Marker of Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Nivolumab
International Journal of Clinical Oncology - Japan
doi 10.1007/s10147-018-1250-2
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2018
Authors
Publisher
Springer Science and Business Media LLC